Puma Biotechnology to Present at the H.C. Wainwright Global Life Sciences Conference

03-02 21:20

BRIEF-Puma Biotechnology And Pierre Fabre Amend Nerlynx License Agreement

02-26 07:40

BRIEF-CANbridge, Puma Biotechnology Agree to Terminate NERLYNX License Agreement and Settle Arbitration

02-26 07:29

BRIEF-Puma Biotechnology Reports Q4 Loss Per Share $0.38

02-26 05:28

Puma Biotechnology 4Q Loss $15M >PBYI

02-26 05:05

Press Release: Puma Biotechnology Reports Fourth Quarter and Full Year Financial Results

02-26 05:05

Press Release: Puma Biotechnology Reports Fourth -3-

02-26 05:05

Press Release: Puma Biotechnology to Host Conference Call to Discuss Fourth Quarter and Full Year 2020 Financial Results

02-12 05:29

Puma Biotechnology: Interim Results For Neratinib Show Clinical Benefit in 8 Patients

01-29 21:35

Puma Biotechnology Presents Interim Results From Phase II SUMMIT Trial Of Neratinib For EGFR Exon 18-Mutated, Metastatic Non-Small Cell Lung Cancer At WCLC 2020

01-29 21:09